Menu
This AmplifyBio poster describes their non-viral gene editing platform (NVGE™) for engineering T cells for adoptive cell therapy. This platform can be utilized to knock out multiple genes and express transgenes in a single step at both research and GMP manufacturing scales and can be adapted to multiple types of cell therapy manufacturing processes.
AmplifyBio couples dedicated testing and related CRO services with a skilled team and access to the latest resources. This combination produces groundbreaking research for specialty products and assessments that can be analyzed for implementation in products and processes. Talk with us about your individual requirements and work with our specialists to develop an effective solution.
